
    
      secondary objective

        -  Evaluation of the safety aspects of medicines such as type, frequency and intensity of
           adverse events between groups during the 28 day trial.

      exploratory objective

        -  Evaluation of the pharmacokinetics of the drug administered through the dosage of serum
           hormone levonorgestrel and ethinyl estradiol for 28 days.
    
  